Reviva Pharma RVPH down big.

RVPH

Reviva Pharma RVPH down big on massive volume, to find out why take...

Stay Ahead of the
Stock Market Game!
Subscribe to Small Cap
Exclusive for more

trending

Rtw Investments is Buying Ptc Therapeutics Inc. (NAS...
Guess Who Just Picked Up Egalet Corp. (NASDAQ:EGLT) ...
Park West Is Buying Kindred Biosciences Inc. (NASDAQ...

Reviva Pharma RVPH down big on massive volume, to find out why take a look at this technical analysis by our Alexander Goldman down below

Reviva Pharmaceuticals RVPH Company Summary

Company Name:  Reviva Pharmaceuticals Holdings, Inc.

Ticker: RVPH

Exchange: NASDAQ

Website: https://ir.revivapharma.com/

Reviva Pharmaceutical Company Summary

Reviva Pharma RVPH is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families.

Also, Reviva’s current pipeline focuses on the central nervous system, respiratory and metabolic diseases. Reviva’s pipeline currently includes two drug candidates, RP5063 (brilaroxazine) and RP1208.

Therefore, Both are new chemical entities discovered in-house. Reviva has been granted composition of matter patents for both RP5063 and RP1208 in the United States (U.S.), Europe, and several other countries.

Why did RVPH go down?

Jan. 10th 2021

Reviva Pharma RVPH announced today the U.S. Food and Drug Administration (FDA) has notified the Company that it may proceed with Phase 3 clinical investigation of its lead candidate, brilaroxazine, a novel serotonin and dopamine receptor modulator for the treatment of schizophrenia.

RVPH 3 Month Chart

PSTI

RVPH 1 Day Chart

PSTI

RVPH Technical Analysis

Reviva Pharmaceutical is looking bad, real bad. Don’t put it on your watchlist. It’s bearish all the way around.

Stay in the lopp :

Deltic Timber Corp. (NYSE:DEL) is Attracting ...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Deltic Timber Corp. (NYSE:DEL) reported that Southeastern Asset Management has
Here's Who Just Picked Up Omnova Solutions In...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Omnova Solutions Inc. (NYSE:OMN) reported that Rbc Global Asset Management
Koios to Complete Development of CBD-Enhance...

Following the Company’s September 4, 2018 announcement of plans to release a functional beverage infused with CBD, Koios has resumed development with test batch production

related post

Skip to content